Meet Sancy Leachman, M.D., Ph.D.
The OHSU Department of Dermatology’s 6th chair
Sancy Leachman, M.D., Ph.D.
We are so pleased and excited to welcome our new chair of the Department of Dermatology, Sancy Leachman, M.D., Ph.D. Dr. Leachman comes to OHSU from the University of Utah, where she was director of the Melanoma and Cutaneous Oncology Program in the Huntsman Cancer Institute, a professor in the Department of Dermatology, and member of the Imaging, Diagnostics, and Therapeutics Program and the Cancer Control and Population Sciences Program. Leachman’s transition from Utah will be complete by July 1st, but she has already infused the department with energy and new ideas.
Leachman was a key figure in developing the Melanoma and Cutaneous Oncology Program at Huntsman Cancer Institute, serving as its director, and will bring that expertise to her new position of Director of the Melanoma Research Program at the OHSU Knight Cancer Institute. Her talent in team building will improve the care of patients in our community by bringing together researchers and physicians with an interest in melanoma and other skin cancers in order to bring knowledge and expertise from the laboratory into the clinical realm.
Leachman’s research examines the role of genetic predisposition and differential gene expression in the development of melanoma, with an emphasis on the familial melanoma syndrome. Through her investigations, she is seeking to develop agents that will serve as diagnostic tools, prognostic indicators, or targeted agents for the prevention of melanoma. Her clinical interests include skin cancer, especially melanoma, pigmentary disorders that result from abnormalities of melanocytes such as vitiligo, and genetic disorders that involve the skin such as pachyonychia congenita, Cowden syndrome, and other cutaneous cancer syndromes.
Before joining Huntsman Cancer Institute, Leachman was a resident and fellow in dermatology at Yale University School of Medicine, where she worked on a DNA vaccination study to prevent and treat papillomavirus-induced squamous cell carcinoma. She earned her MD and PhD from the University of Texas Southwestern Medical School, and was awarded the prestigious Doris Duke Clinical Scientist Development Award in 2000. She is currently an NIH R01- and Department of Defense-funded principle investigator.
Want to know more about Sancy? Read a more personal article here.
|Q & A with Dr. Sancy Leachman:|